T. Rowe Price Associates’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.1M Buy
59,203
+6,360
+12% +$119K ﹤0.01% 1945
2025
Q1
$1.01M Buy
52,843
+2,103
+4% +$40.3K ﹤0.01% 1951
2024
Q4
$1.83M Buy
50,740
+5,540
+12% +$200K ﹤0.01% 1689
2024
Q3
$1.92M Buy
45,200
+409
+0.9% +$17.3K ﹤0.01% 1661
2024
Q2
$1.81M Buy
44,791
+6,059
+16% +$244K ﹤0.01% 1604
2024
Q1
$1.37M Buy
38,732
+1,985
+5% +$70.3K ﹤0.01% 1748
2023
Q4
$1.09M Buy
36,747
+1,931
+6% +$57.1K ﹤0.01% 1830
2023
Q3
$724K Buy
34,816
+2,787
+9% +$58K ﹤0.01% 1942
2023
Q2
$786K Sell
32,029
-259,162
-89% -$6.36M ﹤0.01% 1916
2023
Q1
$11.8M Buy
291,191
+925
+0.3% +$37.6K ﹤0.01% 1025
2022
Q4
$13M Sell
290,266
-113,679
-28% -$5.11M ﹤0.01% 1009
2022
Q3
$19.3M Sell
403,945
-231,499
-36% -$11.1M ﹤0.01% 914
2022
Q2
$37.6M Buy
635,444
+7,747
+1% +$459K ﹤0.01% 972
2022
Q1
$73M Buy
627,697
+3,886
+0.6% +$452K 0.01% 835
2021
Q4
$93.9M Sell
623,811
-26,494
-4% -$3.99M 0.01% 788
2021
Q3
$77.6M Sell
650,305
-131,038
-17% -$15.6M 0.01% 853
2021
Q2
$76.1M Sell
781,343
-312,972
-29% -$30.5M 0.01% 883
2021
Q1
$96.6M Sell
1,094,315
-277,065
-20% -$24.5M 0.01% 788
2020
Q4
$131M Buy
1,371,380
+42,692
+3% +$4.08M 0.01% 634
2020
Q3
$151M Buy
1,328,688
+256,413
+24% +$29.1M 0.02% 548
2020
Q2
$106M Buy
1,072,275
+579,116
+117% +$57.3M 0.01% 626
2020
Q1
$31.7M Buy
493,159
+236,324
+92% +$15.2M 0.01% 924
2019
Q4
$15.3M Sell
256,835
-34,582
-12% -$2.06M ﹤0.01% 1239
2019
Q3
$17.2M Buy
291,417
+22,506
+8% +$1.33M ﹤0.01% 1197
2019
Q2
$17.4M Buy
268,911
+20,198
+8% +$1.3M ﹤0.01% 1214
2019
Q1
$15.8M Buy
248,713
+21,323
+9% +$1.35M ﹤0.01% 1240
2018
Q4
$8.63M Sell
227,390
-19,502
-8% -$740K ﹤0.01% 1329
2018
Q3
$10.6M Buy
+246,892
New +$10.6M ﹤0.01% 1358